Structural Formula (Flumazenil 1)
Flumazenil Injection, Solution
Product Images NDC 50090-1337
3 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Flumazenil (NDC 50090-1337). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chart 1 (Flumazenil 2)
A chart showing the magnitude and duration of sedation reversal as a function of flumazenil dose (0.2, 0.6, and 1 mg). The vertical axis represents alertness levels from baseline sedation to completely alert, and the horizontal axis shows time in minutes after flumazenil injection. The chart compares alertness changes at different blood levels of flumazenil, noting sedation produced by midazolam infusion.*
Label Image (Lbl500901337)
Flumazenil 0.5 mg/5 mL (0.1 mg/mL) injection, solution label for intravenous use by A-S Medication Solutions. The label specifies a 5 mL multiple dose vial, storage at 4°C, and includes lot number and distributor information. The label also contains a barcode and handling instructions.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
